Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lion

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Blood|September 15, 1999
Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction and clinical decision makingT Lion
Leukemia|September 1, 1996
Control genes in reverse transcriptase-polymerase chain reaction assaysT Lion
Leukemia|November 1, 1996
Appropriate controls for RT-PCRT Lion
Leukemia|May 1, 1996
Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspectsT Lion
Current Opinion in Hematology|November 5, 1999
Minimal residual diseaseT Lion
Leukemia|January 17, 2003
Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detectionT Lion
Bone Marrow Transplantation|October 1, 1994
Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. The European Investigators on Chronic Myeloid Leukemia GroupT Lion
Leukemia|July 18, 2001
Current recommendations for positive controls in RT-PCR assaysT Lion
British Journal of Haematology|December 1, 1991
Multiprimer-PCR for screening of genetic abnormalities in acute lymphoblastic leukaemiaS Izraeli, T Lion
Leukemia|June 1, 1997
Debate round-table. Appropriate controls for RT-PCRV Kidd, T Lion
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Blood|September 15, 1999
Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction and clinical decision makingT Lion
Leukemia|September 1, 1996
Control genes in reverse transcriptase-polymerase chain reaction assaysT Lion
Leukemia|November 1, 1996
Appropriate controls for RT-PCRT Lion
Leukemia|May 1, 1996
Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspectsT Lion
Current Opinion in Hematology|November 5, 1999
Minimal residual diseaseT Lion
Leukemia|January 17, 2003
Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detectionT Lion
Bone Marrow Transplantation|October 1, 1994
Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. The European Investigators on Chronic Myeloid Leukemia GroupT Lion
Leukemia|July 18, 2001
Current recommendations for positive controls in RT-PCR assaysT Lion
British Journal of Haematology|December 1, 1991
Multiprimer-PCR for screening of genetic abnormalities in acute lymphoblastic leukaemiaS Izraeli, T Lion
Leukemia|June 1, 1997
Debate round-table. Appropriate controls for RT-PCRV Kidd, T Lion
Pageof 10